Introduction
Review
Clinical need for functional imaging techniques
Functional imaging techniques
DCE-MRI
Semi-quantitative analysis
Sequence
|
Plane
|
FOV
|
Slice
|
Gap
|
Matrix
|
NSA
|
---|---|---|---|---|---|---|
DWI 2b-values (0,1200)
| Axial | 400 | 5 | 1 | 112 × 256 | 3 |
DWI 3b-values (0,300,600)
| Axial (sagittal optional for endometrial cancer) | 340 | 6 | 1 | 112 × 256 | 3 |
T1 fat sat
| Adnexal:Axial oblique | 280 | 4 | 224 × 256 | 8 | |
DCE 5 scans
| ||||||
36secs each
| ||||||
Scan time 3 mins
| Cervical and endometrial: Sagittal | 280 | 4 | 208 × 256 | 6 |
Quantitative analysis
DWI-MRI
Clinical application of Functional MRI
Cervical cancer
DCE-MRI as a predictor of radiotherapy response in cervical cancer
Authors
|
Number of patients
|
DCE-MRI parameters
|
Outcome
|
---|---|---|---|
Mayr et al 2010 [31] | 98 | Semi-quantitative RSI throughout treatment | ● Persistent low perfusion associated with poor prognosis |
● Low perfusion which converts to high perfusion during treatment associated with favourable response. | |||
Zahra et al 2009 [19] | 13 | Semi-quantitative and quantitative. Assessed at 3 time points, pre treatment, after 2 weeks of EBRT and in the last week of EBRT | ● semi quantitative and quantitative DCE-MRI parameters correlate significantly with tumour regression at the end of EBRT. |
● Tumors with early peak SI, steeper slope for the TSI curve, and higher values for CER, Ktrans, and kep had more significant tumor regression and response to therapy | |||
Mayr et al 1996 [21] | 17 | Semi-quantitative pre treatment and at 2 weeks EBRT. | ● High pre-treatment SI and steeper slope on TSI curve correlated with lower incidence of local recurrence |
● High perfusion early in therapy is a favourable prognostic factor. | |||
Yuh et al 2009 [32] | 101 | Semi-quantitative volume and perfusion in MRIs at 3 time points | ● Tumor volume, mean SI, and SI% showed significant prediction of the long-term clinical outcome |
Gong et al 1999 [33] | 7 | Semi-quantitative pre-treatment and at 2 weeks | ● Mean and peak enhancement correlated with tumour regression |
Yamashita et al 2000 [1] | 36 | Semi-quantitative | ● Tumours with homogenous contrast enhancement correlated with good responders and poorly enhancing tumours with poor responders |
Post-therapy DCE-MRI in predicting recurrence
DCE-MRI and tumour volume
ADC as a potential biomarker of tumour response
ADC as a biomarker of early response: mid-treatment
Author
|
No
|
Baseline ADC
|
Mid-treatment ADC
|
S % change
|
Post- treatment ADC
|
% change
|
---|---|---|---|---|---|---|
Liu et al
| 15 | CR 0.81 ± 0.08 | 1.25 ± 0.10 | 56% | __________ | |
PR 0.93 ± 0.09 | 1.20 ± 0.17 | 29% | 1.32 ± 0.23 | 42% |